Lowenstein Sandler represented Hildred Capital in the transaction. Hildred Capital raised $750 million for its continuation fund to extend its ownership of two of its portfolio companies, Hyland’s...
Hildred Capital’s $750 Million Continuation Fund
Traub Capital’s Investment in Sabatino Tartufi
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners, a strategic private equity firm specializing in building value in consumer companies using its...
Celularity’s $150 Million At-the-Market Offering
Lowenstein represented BTIG, LLC, Oppenheimer & Co. Inc., and B. Riley Securities, Inc. as sales agents in the offering. Celularity, Inc. executed an at-the-market offering of up...
Crown Laboratories’ Acquisition of Eclipse MedCorp’s Assets
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...